Results showed that in patients with metastatic castration-resistant prostate cancer (mCRPC), CD38 mRNA expression was significantly linked with upregulated immune-signaling pathways, plus interleukin (IL)-12, IL-23, and IL-27 signaling signatures, immunosuppressive adenosine signaling, and T-cell exhaustion signatures.
While CD38 was largely absent from tumor epithelial cells, it was often expressed in phenotypically diverse TIICs, such as B cells and myeloid cells. Moreover, CD38-positive TIIC density was associated with worse overall survival (OS) and increased with progression to castration-resistant prostate cancer (CRPC).
We believe that CD38 on the surface of immune cells is acting to dampen down the immune response. We have shown that the presence of this protein on immune cells within prostate tumors is a sign of worse survival outcomes and exhausted anticancer immune responses, said lead study author Johann de Bono, MD, MSc, PhD, FRCP, FMedSci, professor of experimental cancer medicine at The Institute of Cancer Research in London, and Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust.2 It is now clear that CD38 has a role in prostate cancers growth and spreadsuggesting that targeting it with drugs, which already exist and are used in other cancers, could be a promising new approach to treatment.
OS for patients with mCRPC remains poor at 2 to 3 years, and improving outcomes remains dependent on overcoming immunosuppressive barriers in the prostate tumor microenvironment (TME). CD38 upregulation in TIICs has been observed in some gastrointestinal cancers, though not in prostate cancer; however, increasing data have shown evidence that CD38 expression plays and role in tumor immune evasion, and as such, could factor into disease progression in prostate cancer, and serve as an immunotherapeutic target.
In this study, investigators sought to determine the clinical impact of CD38 expression in patients with mCRPC as they progressed to evaluate the potential use of CD38-directed therapies for the treatment of mCRPC.
For this analysis, RNA-sequencing from 159 patients with mCRPC from the Stand Up To Cancer/Prostate Cancer Foundation (SU2C/PCF) project, as well as 171 samples from 63 patients at the Fred Hutchinson Cancer Research Center, were analyzed for CD38 expression. Samples were then immunohistochemically scored by a validated assay of 51 CRPC biopsies, and matching same-patient castration-sensitive prostate cancer (CSPC) biopsies.
Among these 51 patients, CSPC samples were taken from the prostate (n = 50) and lymph node (n = 1), while CRPC samples were taken from the lymph nodes (n = 30), bone (n = 12), soft tissue (n = 3), liver (n = 3), and prostate (n = 3). mCRPC samples were analyzed for associations between CD38 and other gene expression signatures, while differences in CD38-expressing TIIC densities in the CSPC and CRPC biopsies were evaluated using a negative binomial mixed model. Moreover, multiplex immunofluorescence evaluated CD38 expression.
Results showed that CD38 expression occurred in 35.8% of normal prostatic epithelial cells vs 7.7% of tumor epithelium cells (P < .001). Additionally, the rates of CD38 expression were similar between CSPC and CRPC biopsies, at 9.8% and 3.9%, respectively (P = .45).
In the CSPC samples analyzed, CD38-positive TIIC density was associated with worse OS outcomes from initial diagnosis (HR, 1.36; 95% CI, 1.08-1.70; P = .008). Additionally, high CD38-positive TIIC density, defined as more than 1.5 cells/mm2, was associated with shorter OS from the time of initial diagnosis vs those with low CD38-positive TIIC density (HR, 1.99; 95% CI, 1.09-3.62; P = .02).
Results were similar in the CRPC samples, with CD38-positive TIIC density leading to worse OS outcomes from both the time of biopsy (HR, 1.20; 95% CI, 1.00-1.42; P = .04) and the time of CRPC diagnosis (HR, 1.40; 95% CI, 1.14-1.70; P < .001). Moreover, high CD38-positive TIIC density in these samples was also associated with shorter OS from the time of diagnosis vs low CD38+ TIIC density (HR, 2.24; 95% CI, 1.15-4.00; P = .02).
Additionally, results from a multivariable analysis showed that the CD38-expressing immune cell density seen in CSPC samples lead to worse OS from the time of prostate cancer diagnosis (HR, 1.42; 95% CI, 1.08-1.87; P = .01).
As cancers develop, they often evolve the ability to evade the immune system so they can keep growing and spreading without being attacked. This new study suggests that in prostate cancer, tumors can suppress the immune system via the CD38 molecule on the surface of immune cells, said Paul Workman, FRS, FRSC, FMedSci, chief executive of The Institute of Cancer Research in London. The findings are exciting and open up a whole new potential approach to treating prostate cancer using immunotherapyan approach that is now being tested in clinical trials which have the potential to show real benefit for patients.
Read more:
CD38 Expression Linked With Poor OS in Prostate Cancer - OncLive
- Neutrophil diversity and function in health and disease - Nature.com - December 6th, 2024
- Harnessing the Power of the Immune System for Breast Cancer Treatment - Breast Cancer Research Foundation - December 6th, 2024
- Study Examines Neoantigen Landscapes and Their Role in Immunotherapy Efficacy - Consult QD - December 6th, 2024
- The 5 Best Teas to Support Your Immune System This Cold & Flu Season - EatingWell - December 6th, 2024
- Engineered immune cells may be able to tame inflammation - Medical Xpress - December 6th, 2024
- Hybrid model of tumor growth, angiogenesis and immune response yields strategies to improve antiangiogenic therapy - Nature.com - December 6th, 2024
- Opioids interfere with cancer immunotherapy, but another type of drug could help - Medical Xpress - December 6th, 2024
- RANKL cytokine restores thymus cells in old mice, reducing tumor growth and improving T cell immune response - Fierce Biotech - December 6th, 2024
- Predictive role of neutrophil percentage-to-albumin ratio, neutrophil-to-lymphocyte ratio, and systemic immune-inflammation index for mortality in... - December 6th, 2024
- Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target... - December 6th, 2024
- Study cracks the cold case of immunotherapy resistance - News-Medical.Net - December 6th, 2024
- New immune therapy improves survival and reduces tumor burden in glioblastoma - News-Medical.Net - December 6th, 2024
- Identification of immune-related hub genes and potential molecular mechanisms involved in COVID-19 via integrated bioinformatics analysis - Nature.com - December 6th, 2024
- Immune Cell Breakthrough: Scientists Discover a Hidden Ally in the Fight Against Cancer - SciTechDaily - December 6th, 2024
- Rising temperatures impact the immune system of wild monkeys - Earth.com - December 6th, 2024
- Study declaring Alzheimer's to be a "brain disease" proven to be fabricated - Earth.com - December 6th, 2024
- Warming temperatures impact immune performance of wild monkeys, U-M study shows - University of Michigan News - December 6th, 2024
- New study explores heart risks of cancer immunotherapy - News-Medical.Net - December 6th, 2024
- 'Incredible' way to boost your immune system naturally and ward of colds and flu this winter - The Mirror - December 6th, 2024
- Tis the Season to Boost Your Immune System - Mix93.3 - December 6th, 2024
- A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies - Nature.com - October 14th, 2024
- Fox Chase Cancer Center Researchers Find Gene That Triggers Immune Response in Treatment-Resistant Small-Cell Lung Cancer - Fox Chase Cancer Center - October 14th, 2024
- What Does It Mean to Be Immunocompromised? - The New York Times - October 14th, 2024
- Scientist hopes to cure Type 1 diabetes by disguising stem cells - The University of Arizona - October 14th, 2024
- Watching an infection unfold with a sphingolipid probe - Drug Discovery News - October 14th, 2024
- The cells that protect your brain against infection could also be behind some chronic diseases - BBC.com - October 14th, 2024
- On Nutrition: Foods that help strengthen the immune system - LimaOhio.com - October 14th, 2024
- An integral T cell pathway has implications for understanding sex-based immune response - Medical Xpress - October 14th, 2024
- Immune Response Linked to Lewy Body Formation - Neuroscience News - October 14th, 2024
- Are vaccines the future of cancer prevention? - Genetic Literacy Project - October 14th, 2024
- The Gut Microbiome and Autoimmunity - Inside Precision Medicine - October 14th, 2024
- Researchers discover how oral cancer cells may block the body's immune response - News-Medical.Net - September 21st, 2024
- Are Vaccines More Effective When You Believe in Them? - Greater Good Science Center at UC Berkeley - September 21st, 2024
- Researchers discover immune response to dengue can predict risk of severe reinfections - Medical Xpress - September 21st, 2024
- Texas Researchers Find Acid Walls That Shield Cancer Tumors from Bodys Immune System Response - DARKDaily.com - Laboratory News - September 21st, 2024
- Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis - Nature.com - September 21st, 2024
- A new way to reprogram immune cells and direct them toward anti-tumor immunity - MIT News - September 21st, 2024
- Unravelling the many mysteries of the immune system - Cosmos - September 21st, 2024
- Long COVID patients maintain robust immune memory two years after infection - News-Medical.Net - September 21st, 2024
- Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other viral infections - Journal of... - September 21st, 2024
- Which adults benefit from the pneumococcal vaccine? - Mayo Clinic Press - September 21st, 2024
- UAMS receives $2.2 million grant to study immune response to eye disease - talkbusiness.net - September 21st, 2024
- Low oxygen levels in tumors could enhance some of the body's immune responses against cancer - Medical Xpress - September 21st, 2024
- Overview of the Immune System - The Merck Manuals - March 18th, 2024
- What are the organs of the immune system? - InformedHealth.org - NCBI ... - January 17th, 2024
- Mom who homeschools her children reveals she lets her one-year-old play in and EAT mud - but insists it is goo - Daily Mail - November 26th, 2023
- The limits of nutritional supplements: they dont cure or prevent ailments, nor are they harmless - EL PAS USA - November 26th, 2023
- Here's how your gut affects your mental health, immune function and even cardiovascular health - indulgexpress - November 18th, 2023
- From fear to freedom: Anchor Paul LaGrone shares his story of sudden hair loss & the disease that caused it - ABC Action News Tampa Bay - May 9th, 2023
- Strengthen Your Immune System With 4 Simple Strategies - May 1st, 2023
- Immunodeficiency Awareness Month: What Is The Science Behind These Diseases? Know Warning Signs - ABP Live - May 1st, 2023
- Nearly 90% of patients with rare skin cancer respond to therapy that prevents tumors from evading the immune - cleveland.com - April 23rd, 2023
- University of Cincinnati researchers helping develop 'vaccine' to fight aggressive cancer - WKRC TV Cincinnati - April 23rd, 2023
- Sana Biotechnology Highlights Preclinical Hypoimmune Data for its Allogeneic CAR T Platform and Advancements with its In Vivo Fusogen Platform with... - April 23rd, 2023
- Immune System: Parts & Common Problems - Cleveland Clinic - March 21st, 2023
- Disorders of the Immune System | Johns Hopkins Medicine - March 21st, 2023
- Sometimes 15 Minutes Are More Than Enough To Improve Immune System, Sleep Quality And Depression - Revyuh - March 13th, 2023
- People produce endocannabinoids similar to compounds found in marijuana that are critical to many bodily functions - The Conversation Indonesia - February 24th, 2023
- Spending more time with your kids, grandkidsand their germsmay lower risk of a severe outcome from Covid-19, recent studies show - CNBC - December 20th, 2022
- Published in Journal for Immunotherapy of Cancer: Using Single-Cell Analysis to Assess the Effects of an Anti-OX40 Monoclonal Antibody in Its... - November 17th, 2022
- Man who had COVID-19 for 400 days finally cured after getting treated with antibodies, study says - msnNOW - November 17th, 2022
- Social Distancing: The Impact on Your Health and Immune System - Healthline - October 7th, 2022
- Unraveling the Mysteries of the Immune System - Duke University School of Medicine - October 7th, 2022
- When Will ISR Immune System Regulation Holding AB (publ) (STO:ISR) Become Profitable? - Simply Wall St - October 7th, 2022
- VitaGaming Introduces Immune Support and Collagen to help Gamers boost immunity and fight stress - PR Web - October 7th, 2022
- Ohio reports third U.S. death of person with monkeypox who had underlying health conditions - CNBC - October 7th, 2022
- How a select few people have been cured of HIV - PBS - October 7th, 2022
- BeniCaros Wins Nutrition Industry Executive 2022 Immune Health Award - GlobeNewswire - October 7th, 2022
- Seasonal superfoods to give your immune system a boost this autumn - Yahoo Entertainment - October 7th, 2022
- Whats Going Around: Flu cases confirmed locally - ABC27 - October 7th, 2022
- Contributor: How to Fight the Cold and the Flu This Season - AJMC.com Managed Markets Network - October 7th, 2022
- Updated COVID-19 Bivalent Booster Released in Time for Fall and Winter Omicron Wave - Cornell University The Cornell Daily Sun - October 7th, 2022
- Oralair pill that retrains the immune system to reduce risk of thunderstorm asthma - 7NEWS - October 7th, 2022
- COVID immune reaction could affect brain mechanisms and induce neurological symptoms - Sky News - October 7th, 2022
- 7 Surprising Health Benefits of Pumpkins - AARP - October 7th, 2022
- Why Do Some Allergies Go Away While Others Dont? - The Atlantic - October 7th, 2022
- 15 foods to boost the immune system - Medical News Today - September 4th, 2022
- The powerful supplement that could enhance your immune response to bacteria and viruses - Express - September 4th, 2022
- New research: Cancer-fighting viruses can boost body's immune response - The Indian Express - September 4th, 2022
- Long COVID: How researchers are zeroing in on the self-targeted immune attacks that may lurk behind it - The Conversation Indonesia - September 4th, 2022